You are here

Iveric Bio

Iveric drug approved for type of vision loss as rival’s safety draws scrutiny

BioPharma Dive

Sun, 08/6/23 - 09:25 pm

geographic atrophy

5 FDA decisions to watch in the third quarter

BioPharma Dive

Mon, 06/26/23 - 10:04 am

SAGE Therapeutics

With Iveric Bio buyout, Astellas CEO Okamura acted on the company's mantra to be 'aggressive'

Fierce Pharma

Tue, 06/13/23 - 10:43 am

Bayer, Amgen looked at Iveric before agreeing to Astellas sale

Seeking Alpha

Tue, 05/23/23 - 06:20 pm

Astellas to acquire eye drug developer Iveric Bio for $5.9B

BioPharma Dive

Mon, 05/1/23 - 11:13 am

FDA accepts Iveric Bio's NDA, grants priority review for GA drug

Endpoints

Tue, 02/21/23 - 10:12 am

geographic atrophy

Apellis Pharmaceuticals

avacincaptad pegol

Iveric hits again in pivotal eye disease program, keeping it on Apellis' tail in race to market

Fierce Biotech

Tue, 09/6/22 - 10:41 am

Apellis Pharmaceuticals

clinical trials

dry eye disease

geographic atrophy

Why Iveric Bio Is Skyrocketing 24% Today

Motley Fool

Thu, 06/18/20 - 08:20 pm

geographic atrophy

IVERIC bio announces fast track designation from US FDA for Zimura to treat geographic atrophy secondary to dry age-related macular degeneration

Pharmaceutical Business Review

Mon, 04/6/20 - 10:39 am

dry age-related macular degeneration

Iveric bio the latest to be hit by COVID-19 as it delays a key trial

Fierce Biotech

Wed, 03/18/20 - 10:21 am

clinical trials

dry age-related macular degeneration

Ophthotech (now Iveric) hits eye drug goals as shares jump for tiny biotech

Fierce Biotech

Mon, 10/28/19 - 10:36 am

dry age-related macular degeneration

Ophthotech becomes Iveric in pivot to gene therapies

Fierce Biotech

Tue, 04/16/19 - 10:57 am